Literature DB >> 11875669

Humoral immunity and frequency of peritonitis in chronic peritoneal dialysis patients.

H M Poyrazoğlu1, Ruhan Düşünsel, Türkan Patiroğlu, Zübeyde Gündüz, Cengiz Utaş, Tamer Güneş.   

Abstract

This study was designed to investigate the humoral immune status and immunological abnormalities in relation to the pathogenesis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The levels of serum and dialysate total protein, immunoglobulins (IgG, IgA, IgM, and IgG subgroups), and C3 were measured at baseline and at the end of the study in 12 children and 10 adult patients on CAPD. The relationship between the levels of immunoglobulin and C3 and the frequency of peritonitis was investigated. Peritonitis occurred at a frequency of one episode every 3.9 and 6.3 patient-months in children at the beginning and at the end of the study, respectively; however, the respective rates for adult patients were one episode every 5.6 and 9.8 patient-months. The levels of serum immunoglobulin and C3 were normal in adults at the beginning and at the end of the study. However, the levels of serum IgG were low in 4 of 12 pediatric patients. Of the 4 patients with low total IgG, IgA was low in 1 and IgM was low in 2 patients. Of 4 patients with low total IgG, 2 also had low IgG1 and IgG2. However, 3 of the patients with normal IgG had low IgG2 levels at the end of the study. The levels of C3 were low in 6 of 12 and in 3 of 10 pediatric patients at the beginning and at the end of the study, respectively. The protein levels of dialysate were increased at 1-year follow-up in both groups, but the difference was only statistically significant in adult patients (P<0.05). No correlation was found between the levels of serum and dialysate immunoglobulin and the frequency of peritonitis in either group. In this study, hypogammaglobulinemia and hypocomplementemia were determined in pediatric patients undergoing CAPD. Although these immunological deficits are not major factors in the occurrence of CAPD-related peritonitis, they may contribute to the frequency of peritonitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875669     DOI: 10.1007/s00467-001-0742-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Benefits of low dose immunoglobulin in the treatment of refractory CAPD peritonitis and longevity of technical survival on CAPD.

Authors:  Belda Dursun; Murat Tuncer; Rasih Felek; F Fevzi Ersoy
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients.

Authors:  Cécile Courivaud; Karine Bardonnet; Thomas Crepin; Catherine Bresson-Vautrin; Jean-Michel Rebibou; Didier Ducloux
Journal:  J Nephrol       Date:  2015-03-11       Impact factor: 3.902

Review 3.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

4.  WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.

Authors:  Ulrich Matt; Omar Sharif; Rui Martins; Tanja Furtner; Lorene Langeberg; Riem Gawish; Immanuel Elbau; Ana Zivkovic; Karin Lakovits; Olga Oskolkova; Bianca Doninger; Andreas Vychytil; Thomas Perkmann; Gernot Schabbauer; Christoph J Binder; Valery N Bochkov; John D Scott; Sylvia Knapp
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.